Trial Profile
TK-FT Phase 2 Study (Efficacy and Safety Study)
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 31 May 2016
Price :
$35
*
At a glance
- Drugs Fentanyl (Primary)
- Indications Cancer pain
- Focus Adverse reactions; Therapeutic Use
- Sponsors Teikoku Seiyaku
- 31 May 2016 New trial record